• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚乳腺癌患者的肿瘤浸润淋巴细胞(TILs)和免疫组成:空间分布及与危险因素和肿瘤特征的关联。

Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.

机构信息

Department of Pathology, Aga Khan University, East Africa, P.O Box30270- 00100, Nairobi, Kenya.

Division of Anatomical Pathology, University of Cape Town, Cape Town, South Africa.

出版信息

Breast Cancer Res Treat. 2023 Jun;199(2):401-413. doi: 10.1007/s10549-023-06921-3. Epub 2023 Apr 3.

DOI:10.1007/s10549-023-06921-3
PMID:37010652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11568797/
Abstract

BACKGROUND

The immune landscape of breast cancer (BC) in patients from Sub Saharan Africa is understudied. Our aims were to describe the distribution of Tumour Infiltrating Lymphocytes (TILs) within the intratumoural stroma (sTILs) and the leading/invasive edge stroma (LE-TILs), and to evaluate TILs across BC subtypes with established risk factors and clinical characteristics in Kenyan women.

METHODS

Visual quantification of sTILs and LE-TILs were performed on Haematoxylin and eosin -stained pathologically confirmed BC cases based on the International TIL working group guidelines. Tissue Microarrays were constructed and stained with immunohistochemistry (IHC) for CD3, CD4, CD8, CD68, CD20, and FOXP3. Linear and logistic regression models were used to assess associations between risk factors and tumour features with IHC markers and total TILs, after adjusting for other covariates.

RESULTS

A total of 226 invasive BC cases were included. Overall, LE-TIL (mean = 27.9, SD = 24.5) proportions were significantly higher than sTIL (mean = 13.5, SD = 15.8). Both sTILs and LE- TILs were predominantly composed of CD3, CD8, and CD68. We found higher TILs to be associated with high KI67/high grade and aggressive tumour subtypes, although these associations varied by TIL locations. Older age at menarche (≥ 15 vs. < 15 years) was associated with higher CD3 (OR: 2.06, 95%CI:1.26-3.37), but only for the intra-tumour stroma.

CONCLUSION

The TIL enrichment in more aggressive BCs is similar to previously published data in other populations. The distinct associations of sTIL/LE-TIL measures with most examined factors highlight the importance of spatial TIL evaluations in future studies.

摘要

背景

撒哈拉以南非洲地区乳腺癌(BC)患者的免疫景观研究较少。我们的目的是描述肿瘤内基质(sTILs)和主导/浸润边缘基质(LE-TILs)中肿瘤浸润淋巴细胞(TILs)的分布,并评估肯尼亚女性中具有既定风险因素和临床特征的 BC 亚型的 TILs。

方法

根据国际 TIL 工作组指南,对苏木精和伊红染色的病理证实的 BC 病例进行 sTILs 和 LE-TILs 的视觉量化。构建组织微阵列并用免疫组织化学(IHC)染色 CD3、CD4、CD8、CD68、CD20 和 FOXP3。在调整其他协变量后,使用线性和逻辑回归模型评估风险因素和肿瘤特征与 IHC 标志物和总 TILs 之间的关联。

结果

共纳入 226 例浸润性 BC 病例。总体而言,LE-TIL(平均=27.9,SD=24.5)比例明显高于 sTIL(平均=13.5,SD=15.8)。sTILs 和 LE-TILs 主要由 CD3、CD8 和 CD68 组成。我们发现较高的 TILs 与高 Ki67/高分级和侵袭性肿瘤亚型相关,尽管这些关联因 TIL 位置而异。初潮年龄较大(≥15 岁与<15 岁)与较高的 CD3(OR:2.06,95%CI:1.26-3.37)相关,但仅与肿瘤内基质相关。

结论

在更具侵袭性的 BC 中 TIL 富集与其他人群中先前发表的数据相似。sTIL/LE-TIL 测量与大多数检查因素的独特关联突出了在未来研究中进行空间 TIL 评估的重要性。

相似文献

1
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.肯尼亚乳腺癌患者的肿瘤浸润淋巴细胞(TILs)和免疫组成:空间分布及与危险因素和肿瘤特征的关联。
Breast Cancer Res Treat. 2023 Jun;199(2):401-413. doi: 10.1007/s10549-023-06921-3. Epub 2023 Apr 3.
2
Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.肿瘤浸润淋巴细胞(TILs)的形态学评估以研究浸润性乳腺癌的免疫原性、揭示淋巴细胞网络并辅助复发预测:一项回顾性研究
Int J Mol Sci. 2017 Sep 8;18(9):1936. doi: 10.3390/ijms18091936.
3
Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.乳腺癌肿瘤浸润淋巴细胞的异质性及其预后意义。
Histopathology. 2018 Dec;73(6):887-896. doi: 10.1111/his.13695. Epub 2018 Oct 9.
4
Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.乳腺癌中肿瘤浸润淋巴细胞的评估及其与分子亚型、肿瘤分级和分期的相关性。
Breast Dis. 2020;39(2):61-69. doi: 10.3233/BD-200442.
5
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.利用人工智能评估腔面型乳腺癌中的肿瘤浸润淋巴细胞。
Br J Cancer. 2023 Nov;129(11):1747-1758. doi: 10.1038/s41416-023-02451-3. Epub 2023 Sep 30.
6
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.CD3 +、CD4 +和CD8 +肿瘤浸润淋巴细胞(TILs)是乳腺浸润性导管癌生存预后良好的预测指标。
Indian J Med Res. 2014 Sep;140(3):361-9.
7
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.肿瘤浸润淋巴细胞分析揭示了原位乳腺导管癌的两个新的生物学不同亚群。
BMC Cancer. 2018 Feb 3;18(1):129. doi: 10.1186/s12885-018-4013-6.
8
Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.肿瘤浸润淋巴细胞与程序性死亡配体1表达在早期乳腺癌中的预后意义
Clin Breast Cancer. 2016 Feb;16(1):51-8. doi: 10.1016/j.clbc.2015.07.006. Epub 2015 Aug 6.
9
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer.原发性乳腺癌中浸润肿瘤前沿和肿瘤中心的肿瘤浸润免疫细胞的不同模式与新辅助化疗的反应相关。
BMC Cancer. 2019 Feb 4;19(1):120. doi: 10.1186/s12885-019-5320-2.
10
Immunoproteomics Reveal Different Characteristics for the Prognostic Markers of Intratumoral-Infiltrating CD3+ T Lymphocytes and Immunoscore in Colorectal Cancer.免疫蛋白质组学揭示了结直肠癌瘤内浸润CD3+ T淋巴细胞和免疫评分预后标志物的不同特征。
Lab Invest. 2024 Dec;104(12):102159. doi: 10.1016/j.labinv.2024.102159. Epub 2024 Oct 16.

引用本文的文献

1
Tumor-Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers.乳腺癌和女性生殖道癌中的肿瘤浸润淋巴细胞:被忽视的潜力与未被探索的前沿领域。
Cancer Med. 2025 Jul;14(13):e71023. doi: 10.1002/cam4.71023.
2
Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa.撒哈拉以南非洲地区乳腺癌的肿瘤微环境、免疫逃逸和预后因素的区域差异。
Cancer Immunol Res. 2023 Jun 2;11(6):720-731. doi: 10.1158/2326-6066.CIR-22-0795.

本文引用的文献

1
Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age.肿瘤浸润淋巴细胞密度与乳腺癌患者年龄相关的差异及其预后因素。
World J Surg Oncol. 2022 Feb 17;20(1):38. doi: 10.1186/s12957-022-02513-5.
2
Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.肯尼亚乳腺癌患者中乳腺癌分子亚型相关的危险因素。
Breast Cancer Res. 2021 Jun 26;23(1):68. doi: 10.1186/s13058-021-01446-3.
3
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion.黑人女性的乳腺肿瘤微环境:CD8+ T 细胞耗竭的独特特征。
J Natl Cancer Inst. 2021 Aug 2;113(8):1036-1043. doi: 10.1093/jnci/djaa215.
4
Immune gene expression profiling reveals heterogeneity in luminal breast tumors.免疫基因表达谱分析揭示了腔面型乳腺癌的异质性。
Breast Cancer Res. 2019 Dec 19;21(1):147. doi: 10.1186/s13058-019-1218-9.
5
The Immune Microenvironment in Breast Carcinoma: Predictive and Prognostic Role in the Neoadjuvant Setting.乳腺癌中的免疫微环境:新辅助治疗环境中的预测和预后作用。
Pathobiology. 2020;87(2):61-74. doi: 10.1159/000504055. Epub 2019 Nov 12.
6
Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.坦桑尼亚、美国黑人和美国白人女性的乳腺癌:预后和预测特征评估,包括肿瘤浸润淋巴细胞。
PLoS One. 2019 Nov 8;14(11):e0224760. doi: 10.1371/journal.pone.0224760. eCollection 2019.
7
CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis.非转移性乳腺癌中CD68和CD163阳性肿瘤浸润巨噬细胞:一项回顾性研究和荟萃分析
J Cancer. 2019 Jul 23;10(19):4463-4472. doi: 10.7150/jca.33914. eCollection 2019.
8
The Immune Microenvironment of Breast Cancer Progression.乳腺癌进展的免疫微环境
Cancers (Basel). 2019 Sep 16;11(9):1375. doi: 10.3390/cancers11091375.
9
The Immune Landscape of Cancer.癌症的免疫格局
Immunity. 2019 Aug 20;51(2):411-412. doi: 10.1016/j.immuni.2019.08.004.
10
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.T 细胞浸润的组成在不同分子亚型的原发性浸润性乳腺癌以及根据肿瘤大小和淋巴结状态而有所不同。
Virchows Arch. 2019 Jul;475(1):13-23. doi: 10.1007/s00428-019-02568-y. Epub 2019 Apr 17.